Estimating the impact of direct acting antiviral therapy on the prevalence of hepatitis C virus infection using phylogenetics
An adequately powered Bayesian evolutionary analysis using acute stage infection sequences may reproduce the decline in HCV infections observed by traditional epidemiological methods during DAA scale up.
Authors
- Andrew R. Lloyd (ORCID: https://orcid.org/0000-0001-6277-8887)
- Behzad Hajarizadeh (ORCID: https://orcid.org/0000-0003-2212-2028)
- Bethany A. Horsburgh (ORCID: https://orcid.org/0000-0002-4263-2351)
- Chaturaka Rodrigo (ORCID: https://orcid.org/0000-0003-2189-9177)
- Hossain M. S. Sazzad
- Jason Grebely (ORCID: https://orcid.org/0000-0002-1833-2017)
- Gregory J. Dore (ORCID: https://orcid.org/0000-0002-4741-2622)
- Rowena Anne Bull (ORCID: https://orcid.org/0000-0002-9844-3744)
- Hui Li (ORCID: https://orcid.org/0000-0002-3195-5657)
Institutions
- UNSW Sydney (AU)
Publication Details
- Journal
- Virus Research
- Published
- 2025-03-28
- DOI
- https://doi.org/10.1016/j.virusres.2025.199566
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of New South Wales
- National Health and Medical Research Council